Earnings History Data for ZyVersa Therapeutics, Inc. (ZVSA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
ZyVersa Therapeutics, Inc.
ZyVersa Therapeutics Inc. is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop product candidates which address high unmet medical needs in the areas of renal and inflammatory diseases. The company's development pipeline includes phase 2a ready VAR 200 and IC 100. ZyVersa Therapeutics Inc., formerly known as Larkspur Health Acquisition Corp., is based in WESTON, Fla.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | ZVSA | ZyVersa Therapeutics, Inc. | 1.00 | -2.43 | -5.80 | 0.00 | ZyVersa Therapeutics GAAP EPS of -$2.43 misses by $0.83 [11/14/2024 1:52 PM] |
1.12 | -0.13 (-10.40%) |
1.22 | -0.03 (-2.40%) |
1.10 - 42.38 | 239,447 | 6,760,000 | 8,694 | ||
| 09-08-2024 | AH | ZVSA | ZyVersa Therapeutics, Inc. | 3.00 | -3.31 | -5.20 | 0.00 | ZyVersa Therapeutics GAAP EPS of -$3.31 beats by $0.44 [8/9/2024 4:52 PM] |
2.91 | -0.11 (-3.64%) |
3.02 | 0.0 (0.00%) |
2.85 - 79.80 | 22,541 | 50,000 | 891 | ||
|
|
||||||||||||||||||
| 15-05-2024 | PM | ZVSA | ZyVersa Therapeutics, Inc. | 4.00 | -4.53 | -3.70 | 0.00 | 4.92 | -0.38 (-7.09%) |
5.21 | -0.08 (-1.51%) |
4.44 - 180.25 | 53,901 | 200,000 | 3,491 | |||
|
|
||||||||||||||||||
| 25-03-2024 | AH | ZVSA | ZyVersa Therapeutics, Inc. | 1.02 | N/A | -2.14 | 0.00 | ZyVersa Therapeutics GAAP EPS of -$0.29 [3/25/2024 4:07 PM] |
0.7492 | -0.05 (-6.35%) |
0.80 | 0.0 (-0.29%) |
0.50 - 90.65 | 409,618 | 1,070,000 | 33,788 | ||
| 14-11-2023 | AH | ZVSA | ZyVersa Therapeutics, Inc. | 2.00 | -0.09 | -0.16 | 0.00 | ZyVersa Therapeutics GAAP EPS of -$0.09 [11/15/2023 10:18 AM] |
0.0834 | 0.0 (-0.71%) |
0.08 | 0.0 (-2.38%) |
0.07 - 25.00 | 1,047,537 | 10,480,000 | 222,653 | ||